Lucia Ruiz
Overview
Explore the profile of Lucia Ruiz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iborra M, Caballol B, Garrido A, Huguet J, Mesonero F, Ponferrada A, et al.
J Crohns Colitis
. 2024 Aug;
19(1.
PMID: 39171615
Background And Aims: Switching from intravenous infliximab (IV-IFX) to subcutaneous biosimilar infliximab (SC-IFX) has been shown to safely maintain clinical remission and increase drug levels in patients with Crohn's disease...
2.
Casanova M, Nantes O, Varela P, Vela-Gonzalez M, Rivero M, Sierra-Gabarda O, et al.
Aliment Pharmacol Ther
. 2023 Apr;
58(1):60-70.
PMID: 37089065
Background And Aims: Data on the outcomes after switching from adalimumab (ADA) originator to ADA biosimilar are limited. The aim was to compare the treatment persistence, clinical efficacy, and safety...
3.
Huguet J, Garcia-Lorenzo V, Marti L, Paredes J, Ramirez J, Pastor M, et al.
Biomedicines
. 2022 Sep;
10(9).
PMID: 36140230
Background: Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is characterized by chronic relapsing intestinal inflammation. There are few data on the efficacy and safety in clinical practice...
4.
Loarce-Martos J, Larena C, Blazquez M, Joven B, Carreira P, Martinez-Barrio J, et al.
J Clin Rheumatol
. 2021 Jan;
28(1):e195-e202.
PMID: 33492027
Methods: This study reviewed the medical records of patients from the REMICAM cohort, a multicentric longitudinal study carried out in patients with IIM, followed up between 1980 and 2014 in...
5.
Monserrat Sanz J, Bohorquez C, Gomez A, Movasat A, Perez A, Ruiz L, et al.
Int J Mol Sci
. 2020 Sep;
21(18).
PMID: 32961930
CD4T-lymphocytes are relevant in the pathogenesis of rheumatoid arthritis (RA), however, their potential involvement in early RA remains elusive. Methotrexate (MTX) is a commonly used disease-modifying antirheumatic drug (DMARD), but...
6.
Monserrat J, Bohorquez C, Gomez Lahoz A, Movasat A, Perez A, Ruiz L, et al.
Cells
. 2019 Aug;
8(8).
PMID: 31405169
Patients with long-term, treated, rheumatoid arthritis (RA) show abnormalities in their circulating CD4+ T-lymphocytes, but whether this occurs in recently diagnosed naïve patients to disease-modifying drugs (DMARDs) is under discussion....
7.
Guerra I, Bujanda L, Castro J, Merino O, Tosca J, Camps B, et al.
J Crohns Colitis
. 2019 May;
13(12):1492-1500.
PMID: 31063540
Background And Aims: Primary sclerosing cholangitis [PSC] is usually associated with inflammatory bowel disease [IBD]. An increased risk of malignancies, mainly colorectal cancer [CRC] and cholangiocarcinoma [CCA], has been reported...
8.
Medina S, Gomez-Zubiaur A, Valdeolivas-Casillas N, Polo-Rodriguez I, Ruiz L, Izquierdo C, et al.
Eur J Rheumatol
. 2018 Dec;
5(4):224-229.
PMID: 30501848
Objective: Raynaud's phenomenon consists of vasospastic disease of the digital arteries after exposure to cold or stress. It causes an important reduction in the patient's quality of life when severe....
9.
Huguet J, Suarez P, Ferrer-Barcelo L, Ruiz L, Monzo A, Dura A, et al.
World J Gastrointest Endosc
. 2017 Jul;
9(6):255-262.
PMID: 28690768
Screening for colorectal cancer (CRC) in patients with inflammatory bowel disease (IBD) is recommended by all scientific societies. However, there are differences in the recommendations they make regarding screening and...
10.
Sicras-Mainar A, Navarro-Artieda R, Morano R, Ruiz L
Endocrinol Nutr
. 2016 Oct;
63(10):527-535.
PMID: 27744013
Objectives: The main objective was to assess resource use and costs of starting treatment with insulin or injectable GLP-1 receptor analogues (GLP-1 RAs) in a Spanish population of patients with...